Natural Investments LLC Sells 130 Shares of McKesson Corporation $MCK

Natural Investments LLC trimmed its holdings in McKesson Corporation (NYSE:MCK) by 20.3% in the 2nd quarter, Holdings Channel reports. The fund owned 509 shares of the company’s stock after selling 130 shares during the quarter. Natural Investments LLC’s holdings in McKesson were worth $372,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of MCK. Nuveen LLC bought a new stake in McKesson during the 1st quarter valued at about $475,235,000. Wellington Management Group LLP increased its stake in McKesson by 4,559.6% during the 1st quarter. Wellington Management Group LLP now owns 427,703 shares of the company’s stock valued at $287,840,000 after purchasing an additional 418,524 shares in the last quarter. Boston Partners increased its stake in McKesson by 33.3% during the 1st quarter. Boston Partners now owns 1,461,785 shares of the company’s stock valued at $984,927,000 after purchasing an additional 365,484 shares in the last quarter. Voya Investment Management LLC increased its stake in McKesson by 92.3% during the 1st quarter. Voya Investment Management LLC now owns 650,851 shares of the company’s stock valued at $437,760,000 after purchasing an additional 312,473 shares in the last quarter. Finally, 1832 Asset Management L.P. purchased a new stake in shares of McKesson during the 1st quarter valued at about $140,742,000. 85.07% of the stock is currently owned by institutional investors.

McKesson Trading Up 0.8%

MCK opened at $763.89 on Friday. The company has a market cap of $95.01 billion, a price-to-earnings ratio of 30.46, a PEG ratio of 1.38 and a beta of 0.52. The company’s 50 day moving average is $707.48 and its 200 day moving average is $706.39. McKesson Corporation has a 12-month low of $492.39 and a 12-month high of $776.14.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Wednesday, August 6th. The company reported $8.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $8.33 by ($0.07). The business had revenue of $97.83 billion during the quarter, compared to analysts’ expectations of $95.93 billion. McKesson had a negative return on equity of 196.66% and a net margin of 0.84%.The business’s quarterly revenue was up 23.4% compared to the same quarter last year. During the same period in the previous year, the business posted $7.88 EPS. As a group, analysts predict that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 1st. Investors of record on Tuesday, September 2nd were issued a $0.82 dividend. The ex-dividend date of this dividend was Tuesday, September 2nd. This is a positive change from McKesson’s previous quarterly dividend of $0.71. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. McKesson’s payout ratio is 13.08%.

Insider Buying and Selling

In other McKesson news, CEO Brian S. Tyler sold 11,930 shares of McKesson stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $705.63, for a total transaction of $8,418,165.90. Following the transaction, the chief executive officer owned 4,012 shares of the company’s stock, valued at $2,830,987.56. The trade was a 74.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Napoleon B. Rutledge, Jr. sold 329 shares of McKesson stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $663.67, for a total transaction of $218,347.43. Following the transaction, the chief accounting officer directly owned 657 shares in the company, valued at $436,031.19. This represents a 33.37% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 24,189 shares of company stock worth $16,722,190. 0.08% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of analysts have recently issued reports on MCK shares. Bank of America raised their price target on shares of McKesson from $800.00 to $850.00 and gave the company a “buy” rating in a report on Wednesday, September 24th. Wall Street Zen raised shares of McKesson from a “hold” rating to a “buy” rating in a report on Sunday, September 28th. Cowen reaffirmed a “buy” rating on shares of McKesson in a report on Wednesday, September 24th. UBS Group raised their price target on shares of McKesson from $820.00 to $860.00 and gave the company a “buy” rating in a report on Wednesday, September 24th. Finally, JPMorgan Chase & Co. raised their price target on shares of McKesson from $821.00 to $853.00 and gave the company an “overweight” rating in a report on Friday, September 26th. One research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $829.08.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.